Introduction. High grade serous ovarian cancer (HGSOC) is the deadliest gynecologic malignancy in the world [1]. The HGSOC 5-year survival rate is only 3-19% [2]. The high mortality rates are attributed to a lack of specific symptoms and biomarkers used for HGSOC screening, which leads to late disease diagnosis and early chemoresistance. Moreover, CA125, the only biomarker used in HGSOC patient care is not specific for ovarian cancer and is only recommended for disease monitoring [3]. Thus, HGSOC and other oncogynecolgic diseases are in great need of diagnostic, prognostic, and predictive markers which would help earlier disease detection and aid in choosing the correct treatment.
NOTCH and WNT signaling pathways are both involved in ovary development and are necessary for normal female reproductive organ function. Both pathways interact to govern ovarian angiogenesis and are crucial for ovarian cell survival. The inactivation of the NOTCH and WNT ligand-receptor systems leads to stunted ovarian cell migration and proliferation as well as increased apoptosis [4]. Canonical WNT signaling genes CTNNB1 and FBXW7 are amongst the most commonly mutated sequences in gynecologic malignancies [5], while changes in NOTCH gene expression were previously detected in endometrial cancer [6]. Both NOTCH and WNT signaling pathways are important in HGSOC development, progression and chemoresistance, thus they could be useful as HGSOC biomarkers and targets for treatment.
The aim of this study was to analyze NOTCH receptor and WNT pathway gene expression in tissues from patients with HGSOC and other gynecologic diseases in order to determine gene expression correlations with the disease type and clinical features.
Methods. Tissue samples from 51 patients with ether HGSOC (n=32), non-serous ovarian or endometrial carcinoma (n=10) or benign gynecologic pathologies (n=9) were collected during 2018-2021 at National Cancer Institute. Tissues were used for RNA extraction and subsequent RT-qPCR analysis of NOTCH1-4, CTNNB1, FBXW7 and ARID1A mRNA expression.
Results. NOTCH1, NOTCH2, and NOTCH4 as well as CTNNB1 and FBXW7 expression were significantly altered in HGSOC samples when compared with samples of other gynecologic malignancies and benign pathologies. All HGSOC samples were in the same stage and grade, thus no gene expression correlations with HGSOC clinical features could be made. However, NOTCH4 and CTNNB1 expression were significantly related to CA125 serum concentration.
In conclusion, NOTCH and WNT pathway gene expression are potential diagnostic and prognostic biomarkers for HGSOC. More research is needed in order to determine whether the changes in NOTCH and WNT gene expression are detectable in non-invasively collected samples.